Autopsy report · NCT01208129
Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 10 months before it stopped.
- 458 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Promius Pharma, LLC
- Sponsor type
- Industry
- Conditions
- Onychomycosis
- Interventions
- NAB001; Placebo control
- Participants
- 458
- Sites
- 25
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.